Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Since that discovery, a flurry of gene-editing focused biopharma companies have launched – including Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences and Mammoth Biosciences ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

Beyond Casgevy, CRISPR Therapeutics continues ... In the realm of in vivo gene editing, CRISPR Therapeutics is progressing with programs such as CTX310 and CTX320, targeting cardiovascular diseases.

CRISPR can be used to make other types of edits too, such as increasing or decreasing the effects of a gene temporarily. Regardless of the type of editing, the process generally remains limited to ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Gene editing is now reaching the mainstream, ushering in a new era of genetic manipulation. Traditionally, inserting or deleting entire genes, regulating their expression, and altering specific ...

BENGALURU, India, Jan. 16, 2025 /PRNewswire/ -- Bengaluru-based biotechnology startup, CrisprBits Private Limited, has inaugurated a CRISPR gene editing and diagnostics laboratory in Bengaluru.

CRISPR Therapeutics is a mid-stage biotech specializing in gene editing. It became the first gene-editing treatment that uses the Nobel Prize-winning CRISPR technique, an impressive achievement by ...